These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32149968)

  • 21. Nonsurgical Management of Medication-Related Osteonecrosis of the Jaws Using Local Wound Care.
    Hadaya D; Soundia A; Freymiller E; Grogan T; Elashoff D; Tetradis S; Aghaloo TL
    J Oral Maxillofac Surg; 2018 Nov; 76(11):2332-2339. PubMed ID: 29932939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the Treatment Strategies for Medication-Related Osteonecrosis of the Jaws (MRONJ) and the Factors Affecting Treatment Outcome: A Multicenter Retrospective Study with Propensity Score Matching Analysis.
    Hayashida S; Soutome S; Yanamoto S; Fujita S; Hasegawa T; Komori T; Kojima Y; Miyamoto H; Shibuya Y; Ueda N; Kirita T; Nakahara H; Shinohara M; Umeda M
    J Bone Miner Res; 2017 Oct; 32(10):2022-2029. PubMed ID: 28585700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral-Health-Related Quality of Life After Surgical Treatment of Osteonecrosis of the Jaws.
    Oteri G; De Ponte FS; Runci M; Peditto M; Marcianò A; Cicciù M
    J Craniofac Surg; 2018 Mar; 29(2):403-408. PubMed ID: 29135723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonate and Medication-Related Osteonecrosis of the Jaw: A Review.
    Mücke T; Krestan CR; Mitchell DA; Kirschke JS; Wutzl A
    Semin Musculoskelet Radiol; 2016 Jul; 20(3):305-314. PubMed ID: 27741546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
    Nisi M; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
    J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A technique for the treatment of oral-antral fistulas resulting from medication-related osteonecrosis of the maxilla: the combined buccal fat pad flap and radical sinusotomy.
    Melville JC; Tursun R; Shum JW; Young S; Hanna IA; Marx RE
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Sep; 122(3):287-91. PubMed ID: 27307069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws.
    Klingelhöffer C; Zeman F; Meier J; Reichert TE; Ettl T
    J Craniomaxillofac Surg; 2016 Oct; 44(10):1694-1699. PubMed ID: 27591091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human amniotic membrane: an improvement in the treatment of Medication-related osteonecrosis of the jaw (MRONJ)? A case-control study.
    Ragazzo M; Val M; Montagner G; Trojan D; Fusetti S; Guarda Nardini L
    Cell Tissue Bank; 2022 Mar; 23(1):129-141. PubMed ID: 33856589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Differences in Autofluorescence Between Viable and Nonvital Bone: A Case Report With Histopathologic Evaluation Performed on Medication-Related Osteonecrosis of the Jaws.
    Giovannacci I; Meleti M; Corradi D; Vescovi P
    J Oral Maxillofac Surg; 2017 Jun; 75(6):1216-1222. PubMed ID: 28061356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can Surgical Management Improve Resolution of Medication-Related Osteonecrosis of the Jaw at Early Stages? A Prospective Cohort Study.
    Giudice A; Barone S; Diodati F; Antonelli A; Nocini R; Cristofaro MG
    J Oral Maxillofac Surg; 2020 Nov; 78(11):1986-1999. PubMed ID: 32615096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication-related osteonecrosis of the jaw: An institution's experience.
    Altay MA; Radu A; Pack SE; Yıldırımyan N; Flores-Hidalgo A; Baur DA; Quereshy FA
    Cranio; 2020 Sep; 38(5):333-341. PubMed ID: 30296919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-layer closure techniques after bone surgery of medication-related osteonecrosis of the jaw - A single center cohort study.
    Ristow O; Rückschloß T; Bodem J; Berger M; Bodem E; Kargus S; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2018 May; 46(5):815-824. PubMed ID: 29631942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The assessment of surgical and non-surgical treatment of stage II medication-related osteonecrosis of the jaw.
    Eguchi T; Kanai I; Basugi A; Miyata Y; Inoue M; Hamada Y
    Med Oral Patol Oral Cir Bucal; 2017 Nov; 22(6):e788-e795. PubMed ID: 29053660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of surgical intervention and antibiotics on MRONJ stage II and III - Retrospective study.
    Zirk M; Kreppel M; Buller J; Pristup J; Peters F; Dreiseidler T; Zinser M; Zöller JE
    J Craniomaxillofac Surg; 2017 Aug; 45(8):1183-1189. PubMed ID: 28684074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical treatment of stage 2 medication-related osteonecrosis of the jaw compared to osteomyelitis.
    Kang SH; Won YJ; Kim MK
    Cranio; 2018 Nov; 36(6):373-380. PubMed ID: 28854059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ).
    Ristow O; Otto S; Troeltzsch M; Hohlweg-Majert B; Pautke C
    J Craniomaxillofac Surg; 2015 Mar; 43(2):290-3. PubMed ID: 25541255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical treatment of 61 consecutive patients with maxillary stage 3 medication-related osteonecrosis of the jaws using a pedicled buccal fat pad.
    Andersen SWM; Mogensen DG; Schioedt M; Kofod T
    Oral Maxillofac Surg; 2023 Jun; 27(2):251-261. PubMed ID: 35362853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
    Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laser and Platelet-Rich Plasma to treat Medication-Related Osteonecrosis of the Jaws (MRONJ): a case report.
    Fornaini C; Cella L; Oppici A; Parlatore A; Clini F; Fontana M; Lagori G; Merigo E
    Laser Ther; 2017 Sep; 26(3):223-227. PubMed ID: 29133970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.